Drug Profile
Rheumatoid arthritis vaccine - Veterans Affairs Medical Center
Latest Information Update: 01 May 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antirheumatics; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 09 Jan 1996 New profile
- 09 Jan 1996 Preclinical development for Rheumatoid arthritis in USA (Unknown route)